GlassScriptPhysician profile
Lauren M Mckay
NPI 1659741106
$589.22
in general payments reported to CMS, 2019-2025
12 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $44.84 · 2023: $63.21 · 2024: $112 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $139.64 | 2025 | Omnipod |
| Corcept Therapeutics | $131.59 | 2024-2025 | Korlym |
| Abbvie INC. | $101.14 | 2022-2025 | |
| Lilly USA, LLC | $36.17 | 2024-2025 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $33.00 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $31.93 | 2024-2025 | |
| Inspire Medical Systems, INC. | $31.78 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $28.52 | 2023 | Farxiga |
| Reprise Biomedical, INC. | $15.10 | 2025 | Miro3d |
| Biohaven Pharmaceutical Holding Company LTD. | $14.29 | 2022 | |
| Novo Nordisk INC | $13.36 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Mckay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.